Lee Frank D. (CIK 1814686) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-26). Recent activity: Buy BHC (45,871 shares), Sell BHC (24,456 shares), Buy PCRX (261,818 shares), Sell PCRX (41,488 shares), Sell PCRX (9,272 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-26 | Bausch Health Companies Inc. (BHC) | Director | Buy | 45,871 | $0 |
| 2026-05-20 | Bausch Health Companies Inc. (BHC) | Director | Sell | 24,456 | $132,796 |
| 2026-02-13 | Pacira BioSciences, Inc. (PCRX) | Chief Executive Officer | Buy | 261,818 | $0 |
| 2026-02-03 | Pacira BioSciences, Inc. (PCRX) | Chief Executive Officer | Sell | 41,488 | $852,164 |
| 2026-01-06 | Pacira BioSciences, Inc. (PCRX) | Chief Executive Officer | Sell | 9,272 | $226,793 |
| 2025-08-22 | Bausch Health Companies Inc. (BHC) | Director | Sell | 15,912 | $121,886 |
| 2025-05-20 | Bausch Health Companies Inc. (BHC) | Director | Buy | 54,347 | $0 |
Source: SEC Form 4 filings · as of 2026-05-26